Peregrine Pharmaceuticals | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Celldex Therapeutics USD 8.83M 611K 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
MannKind USD 20.54M 3.44M 2023-12
Merck USD 2.75B 272M 2023-12
Repligen USD 57.51M 3.31M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Xencor USD 15.48M 2.98M 2023-12



Peregrine Pharmaceuticals Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.